东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02348 东瑞制药

未开盘 01-08 16:08:05

1.190

-0.010

-0.83%

最高1.200	最低1.190	成交量8.80万
今开1.200	昨收1.200	日振幅0.83%
总市值17.87亿	流通市值17.87亿	总股本15.02亿
成交额10.50万	换手率0.01%	流通股本15.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":1.19,"timestamp":1736323685016,"preClose":1.2,"halted":0,"volume":88000,"delay":0,"floatShares":1502000000,"shares":1502000000,"eps":0.23002978699237595,"marketStatus":"未开盘","change":-0.01,"latestTime":"01-08 16:08:05","open":1.2,"high":1.2,"low":1.19,"amount":105040,"amplitude":0.008333,"askPrice":1.2,"askSize":40000,"bidPrice":1.18,"bidSize":40000,"shortable":0,"etf":0,"ttmEps":0.39679048358487634,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736386200000},"marketStatusCode":0,"adr":0,"listingDate":1057852800000,"exchange":"SEHK","adjPreClose":1.2,"dividendRate":0.06472,"openAndCloseTimeList":[[1736299800000,1736308800000],[1736312400000,1736323200000]],"volumeRatio":0.46009389650300864,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"2492512419","title":"主席李其玲增持东瑞制药(02348)18.4万股 每股作价1.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492512419","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492512419?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:05","pubTimestamp":1734437100,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，12月13日，主席李其玲增持东瑞制药(02348)18.4万股，每股作价1.2港元，总金额为22.08万港元。增持后最新持股数目为7.08亿股，最新持股比例为47.14%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-17/doc-inczurfi4699083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2488988539","title":"主席李其玲增持东瑞制药(02348)8.8万股 每股作价约1.21港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488988539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488988539?lang=zh_cn&edition=full","pubTime":"2024-12-03 16:26","pubTimestamp":1733214376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月29日，主席李其玲增持东瑞制药(02348)8.8万股，每股作价1.2132港元，总金额为10.68万港元。增持后最新持股数目为7.07亿股，持股比例为47.08%。本交易涉及其他关联方：熊融礼。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2480327046","title":"东瑞制药盘中异动 快速上涨7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480327046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480327046?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:42","pubTimestamp":1730706161,"startTime":"0","endTime":"0","summary":"2024年11月04日临近收盘15时42分，东瑞制药股票出现波动，股价急速上涨7.26%。截至发稿，该股报1.330港元/股，成交量7.6万股，换手率0.01%，振幅8.06%。资金方面，该股资金流入5320港元，流出7.932万港元。东瑞制药股票所在的药品行业中，整体涨幅为0.46%。其相关个股中，信达生物、中国医疗集团、海王英特龙涨幅较大，振幅较大的相关个股有顺腾国际控股、兴科蓉医药、三爱健康集团，振幅分别为22.22%、18.75%、10.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2479247918","title":"东瑞制药股价上涨11.20% 市值涨2.34亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479247918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479247918?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:58","pubTimestamp":1730271483,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘14时58分，东瑞制药股票出现异动，股价大幅上涨11.20%。截至发稿，该股报1.390港元/股，成交量3.6万股，换手率0.00%，振幅12.00%。资金方面，该股资金流入5560港元，流出3.972万港元。东瑞制药股票所在的药品行业中，整体跌幅为0.56%。其相关个股中，开拓药业-B、艾美疫苗、白花油涨幅较大，振幅较大的相关个股有翰森制药、泰凌医药、德琪医药-B，振幅分别为12.52%、12.12%、11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2474315255","title":"东瑞制药盘中异动 大幅跳水6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474315255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474315255?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:02","pubTimestamp":1728439365,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘10时02分，东瑞制药股票出现波动，股价大幅下跌6.92%。截至发稿，该股报1.210港元/股，成交量57.2万股，换手率0.04%，振幅2.31%。东瑞制药股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，三爱健康集团、培力农本方、康臣药业涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、华控康泰，振幅分别为32.98%、17.08%、12.50%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2473413976","title":"东瑞制药(02348)下跌8.63%，报1.27元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473413976","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473413976?lang=zh_cn&edition=full","pubTime":"2024-10-08 14:59","pubTimestamp":1728370783,"startTime":"0","endTime":"0","summary":"10月8日，东瑞制药(02348)盘中下跌8.63%，截至14:59，报1.27元/股，成交118.1万元。东瑞制药主要从事头孢类抗生素和系统专科药物的开发、制造及销售，拥有多家子公司，业务覆盖心血管系统、抗乙肝病毒、抗过敏、消化系统、泌尿系统和内分泌系统等多个领域。公司在头孢类抗生素生产方面拥有综合性生产特色，并设有50人的研发中心，每年研发投入约占专科药物销售金额的10%，在全国设有90多个办事处，拥有550名销售人员。截至2024年中报，东瑞制药营业总收入5.77亿元、净利润4.93亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/08145943757962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2473461132","title":"东瑞制药盘中异动 早盘急速跳水6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473461132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473461132?lang=zh_cn&edition=full","pubTime":"2024-10-08 10:36","pubTimestamp":1728355013,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘10时36分，东瑞制药股票出现异动，股价急速下跌6.47%。截至发稿，该股报1.300港元/股，成交量3.6万股，换手率0.00%，振幅2.16%。东瑞制药股票所在的药品行业中，整体跌幅为1.45%。其相关个股中，华控康泰、顺腾国际控股、长江生命科技涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、康龙化成，振幅分别为92.86%、45.18%、32.64%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2473143227","title":"东瑞制药盘中异动 临近午盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473143227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473143227?lang=zh_cn&edition=full","pubTime":"2024-10-07 11:40","pubTimestamp":1728272456,"startTime":"0","endTime":"0","summary":"2024年10月07日临近午盘11时40分，东瑞制药股票出现波动，股价急速上涨5.65%。截至发稿，该股报1.310港元/股，成交量254万股，换手率0.17%，振幅7.26%。东瑞制药股票所在的药品行业中，整体涨幅为0.22%。其相关个股中，三爱健康集团、德琪医药-B、四环医药涨幅较大，振幅较大的相关个股有三爱健康集团、德琪医药-B、艾美疫苗，振幅分别为152.70%、35.05%、28.89%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007114056a1de9aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007114056a1de9aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2473455471","title":"东瑞制药(02348)上涨5.65%，报1.31元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473455471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473455471?lang=zh_cn&edition=full","pubTime":"2024-10-07 11:40","pubTimestamp":1728272454,"startTime":"0","endTime":"0","summary":"10月7日，东瑞制药(02348)盘中上涨5.65%，截至11:40，报1.31元/股，成交321.67万元。东瑞制药主要从事头孢类抗生素和系统专科药物的开发、制造及销售，拥有多家子公司，业务覆盖心血管系统、抗乙肝病毒、抗过敏、消化系统、泌尿系统和内分泌系统等多个领域。公司在头孢类抗生素生产方面拥有综合性生产特色，并设有50人的研发中心，每年研发投入约占专科药物销售金额的10%，在全国设有90多个办事处，拥有550名销售人员。截至2024年中报，东瑞制药营业总收入5.77亿元、净利润4.93亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/07114043737428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2472813996","title":"东瑞制药(02348)根据2023购股权计划授出合共1600万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2472813996","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472813996?lang=zh_cn&edition=full","pubTime":"2024-10-03 07:37","pubTimestamp":1727912244,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布公告，于2024年10月2日，公司根据2023购股权计划...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_21.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_21.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2471815452","title":"东瑞制药盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471815452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471815452?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:37","pubTimestamp":1727660221,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时37分，东瑞制药股票出现波动，股价快速拉升5.26%。截至发稿，该股报1.200港元/股，成交量86.8万股，换手率0.06%，振幅5.26%。东瑞制药股票所在的药品行业中，整体涨幅为0.35%。其相关个股中，艾美疫苗、康龙化成、德琪医药-B涨幅较大，振幅较大的相关个股有艾美疫苗、德琪医药-B、凯莱英，振幅分别为17.13%、16.18%、6.22%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300937019f1ffcd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300937019f1ffcd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2467503768","title":"东瑞制药(02348.HK)委任总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2467503768","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467503768?lang=zh_cn&edition=full","pubTime":"2024-09-16 10:06","pubTimestamp":1726452360,"startTime":"0","endTime":"0","summary":"东瑞制药(02348.HK) 公布，于丽伟已获委任为公司总裁，于上周五(13日)起生效。(js/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240129112558205_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240129112558205_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1381534/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2467385915","title":"东瑞制药公布于丽伟获委任为公司总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2467385915","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467385915?lang=zh_cn&edition=full","pubTime":"2024-09-16 08:28","pubTimestamp":1726446480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　东瑞制药（02348）发布公告，于丽伟女士（于女士）已获委任为公司总裁，于2024年9月13日起生效。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-09-16/doc-incphyza7099789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2467775361","title":"东瑞制药(02348)：于丽伟获委任为公司总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2467775361","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467775361?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:49","pubTimestamp":1726235359,"startTime":"0","endTime":"0","summary":"东瑞制药(02348)发布公告，于丽伟女士(于女士)已获委任为公司总裁，于2024...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_35.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_35.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2466620158","title":"东瑞制药：2024年上半年营收577,447千元，税前利润达556,752千元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466620158","media":"金融界港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466620158?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:15","pubTimestamp":1726132524,"startTime":"0","endTime":"0","summary":"毛利为337,912千元，较2023年同期的361,849千元下降6.6%，毛利率增加了2.8个百分点，达到58.5%。公司在期间出售一家联营公司，获得收益286,670千元。税前利润为556,752千元，较2023年同期的327,211千元增加70.2%，归属于母公司股东的净利润为493,046千元，较2023年同期的255,941千元增加92.6%，净利率增加46个百分点，达到85.4%。基本每股收益为0.3286元人民币，同比增加92.5%。每股净资产价值增加16.2%，为2.180元人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/12171543209374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02348"],"gpt_icon":0},{"id":"2466040560","title":"东瑞制药(02348.HK)总裁辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2466040560","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466040560?lang=zh_cn&edition=full","pubTime":"2024-09-11 17:51","pubTimestamp":1726048260,"startTime":"0","endTime":"0","summary":"东瑞制药(02348.HK) 公布，吴伟贤因需专注于其他个人事务，彼已提呈辞任总裁及其于附属公司层面的其它董事职务。他的辞任自即日生效，其后，他将不再于集团担任任何职务。公司现正物色合适候选人以填补总裁空缺。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240129112558205_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240129112558205_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1380724/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2466403166","title":"东瑞制药(02348)：吴伟贤辞任公司总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2466403166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466403166?lang=zh_cn&edition=full","pubTime":"2024-09-11 17:48","pubTimestamp":1726048116,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，吴伟贤先生(吴先生)因需专注于其他个人事务，彼已提呈辞任公司总裁(总裁)及其于公司的附属公司层面的其它董事职务。吴先生的辞任将于2024年9月11日下午五时正生效，其后，吴先生将不再于集团担任任何职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2462193600","title":"东瑞制药将于10月3日派发中期股息每股0.015港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462193600","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462193600?lang=zh_cn&edition=full","pubTime":"2024-08-26 07:28","pubTimestamp":1724628519,"startTime":"0","endTime":"0","summary":"东瑞制药（02348）发布公告，该公司将于2024年10月3日派发中期股息每股0.015港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-26/doc-inckximm9977153.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-26/doc-inckximm9977153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2462600388","title":"东瑞制药公布中期业绩 母公司拥有人应占溢利约4.93亿元同比增长92.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462600388","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462600388?lang=zh_cn&edition=full","pubTime":"2024-08-26 07:25","pubTimestamp":1724628319,"startTime":"0","endTime":"0","summary":"东瑞制药（02348）公布2024年中期业绩，收入约5.77亿元，同比减少11.2%；毛利约3.38亿元，同比减少6.6%；母公司拥有人应占溢利约4.93亿元，同比增长92.6%；每股基本盈利0.3286元，每股中期股息0.015港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-26/doc-inckximr8502724.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-26/doc-inckximr8502724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2461515190","title":"东瑞制药(02348)公布中期业绩 母公司拥有人应占溢利约4.93亿元 同比增长92.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461515190","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461515190?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:59","pubTimestamp":1724425167,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药 公布2024年中期业绩，收入约5.77亿元，同比减少11.2%;毛利约3.38亿元，同比减少6.6%;母公司拥有人应占溢利约4.93亿元，同比增长92.6%;每股基本盈利0.3286元，每股中期股息0.015港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02348","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":-0.0246},{"period":"1month","weight":0},{"period":"3month","weight":-0.0403},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.1377},{"period":"ytd","weight":-0.0246}],"compareEarnings":[{"period":"1week","weight":-0.0389},{"period":"1month","weight":-0.0556},{"period":"3month","weight":-0.0928},{"period":"6month","weight":0.0539},{"period":"1year","weight":0.1908},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药（控股）有限公司是一家投资控股公司，主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务，包括抗生素制剂药及非抗生素制剂药。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002789},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.004848},{"month":3,"riseRate":0.47619,"avgChangeRate":0.02214},{"month":4,"riseRate":0.714286,"avgChangeRate":0.041272},{"month":5,"riseRate":0.47619,"avgChangeRate":0.014883},{"month":6,"riseRate":0.571429,"avgChangeRate":0.007975},{"month":7,"riseRate":0.52381,"avgChangeRate":0.01431},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.015822},{"month":9,"riseRate":0.5,"avgChangeRate":0.025931},{"month":10,"riseRate":0.409091,"avgChangeRate":-0.00282},{"month":11,"riseRate":0.545455,"avgChangeRate":0.036156},{"month":12,"riseRate":0.590909,"avgChangeRate":0.014253}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}